The guidance states elective surgeries should only be performed after a patient clinically recovers from the infection, and “even then, only when the anesthesiologist, surgeon or proceduralist and patient together agree to proceed,” a June 20 ASA press release said.
The organizations recommend that elective surgeries not occur within two weeks of a COVID-19 infection. Between two and seven weeks after infection, clinicians should conduct a risk assessment of the patient. If the risk is low, the surgery can be scheduled. A delay beyond seven weeks should be considered for patients who continue to have COVID-19 symptoms.
The decision should be based on whether the patient is infectious and clinicians’ opinions on the appropriate time to wait between recovery and surgery based on the patient and surgery-specific risks.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
